More on ALLO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.34 |
|
|||
| Open | $1.34 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.34 | ||||
| Day Low | $1.29 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 4,919,070 | ||||
- Form SCHEDULE 13D/A Allogene Therapeutics, Filed by: TPG GP A, LLC
- Allogene (ALLO) Reiterated at Market Outperform by Citizens on Progress in Autoimmune Diseases
- Form 8-K Allogene Therapeutics, For: Aug 31
- Allogene Therapeutics CFO Geoffrey Parker to retire in November
- Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker
- Allogene Therapeutics Announces Participation in September Investor Conference
- Form 4 Allogene Therapeutics, For: Aug 21 Filed by: Douglas Earl Martin
- Form 144 Allogene Therapeutics, Filed by: Douglas Earl Martin
- Form EFFECT Allogene Therapeutics,
- Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
Entities mentioned with ALLO
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
